Works matching IS 1934662X AND DT 2023 AND VI 131 AND IP 3
Results: 10
The "preexisting condition" invention in American health care: The persistence of a potential insurance nightmare: In this first part of a two‐part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 149, doi. 10.1002/cncy.22686
- By:
- Publication type:
- Article
A distinctive cytomorphological feature of interstitial pneumonia–related lung adenocarcinoma: The potential issues and solutions in practical diagnosis.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 198, doi. 10.1002/cncy.22666
- By:
- Publication type:
- Article
Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high‐grade serous carcinoma from ascites.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 188, doi. 10.1002/cncy.22664
- By:
- Publication type:
- Article
A simplified molecular method to detect high‐risk HPV using the Aptima HPV assay on head and neck FNA smears.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 171, doi. 10.1002/cncy.22662
- By:
- Publication type:
- Article
Cutoff values of PD‐L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 179, doi. 10.1002/cncy.22661
- By:
- Publication type:
- Article
Utility of high‐risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid‐based preparations from metastatic head and neck squamous cell carcinoma.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 165, doi. 10.1002/cncy.22659
- By:
- Publication type:
- Article
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 158, doi. 10.1002/cncy.22657
- By:
- Publication type:
- Article
Development and validation of an RNA sequencing–based classifier for medullary thyroid carcinoma on thyroid FNA.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 154, doi. 10.1002/cncy.22643
- By:
- Publication type:
- Article
Beyond PD‐L1: Assessment of LAG‐3 and other predictive biomarkers in non–small cell lung carcinoma.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 151, doi. 10.1002/cncy.22640
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 3, p. 145, doi. 10.1002/cncy.22463
- Publication type:
- Article